Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

Phase 2

Completed

Conditions: Signet Ring Adenocarcinoma of the Colon
Mucinous Adenocarcinoma of the Colon
Stage IV Rectal Cancer
Recurrent Colon Cancer
Adenocarcinoma of the Rectum
Recurrent Rectal Cancer
Stage IV Colon Cancer

Interventions: Biological: cetuximab
Biological: bevacizumab
Drug: oxaliplatin
Drug: leucovorin calcium
Drug: fluorouracil

First Posted Date: 2005-01-07

Last Posted Date: 2015-07-27

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 66

Registration Number: NCT00100841

Locations: 🇺🇸
Montefiore Medical Center, Bronx, New York, United States

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Phase 3

Completed

Conditions: Chronic Hepatitis C

Interventions: Drug: Pegylated Interferon/ribavirin

First Posted Date: 2005-01-05

Last Posted Date: 2018-10-24

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 114

Registration Number: NCT00100659

Locations: 🇺🇸
Children's Hospital and Regional Medical Center, Seattle, Washington, United States
🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

and more 8 locations

Donor Recipient Kidney Function Following Open Surgical vs. Laparoscopic Kidney Donation

Completed

Conditions: Kidney Transplantation

First Posted Date: 2005-01-03

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 40

Registration Number: NCT00100516

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study

Terminated

Conditions: Pancreatic Neoplasms

First Posted Date: 2004-12-29

Last Posted Date: 2019-12-17

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 25

Registration Number: NCT00100321

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial

Phase 2

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Drug: Mycophenolate mofeteil (MMF)
Drug: Placebo control for Mycophenolate mofeteil (MMF)
Drug: Daclizumab (DZB)
Drug: Placebo control for Daclizumab (DZB)

First Posted Date: 2004-12-24

Last Posted Date: 2020-05-05

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 126

Registration Number: NCT00100178

Locations: 🇺🇸
Childrens Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
University of California-San Francisco, San Francisco, California, United States
🇺🇸
Joslin Diabetes Center, Boston, Massachusetts, United States

and more 8 locations

Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units

Phase 3

Completed

Conditions: Candidiasis

First Posted Date: 2004-12-20

Last Posted Date: 2008-03-04

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 1200

Registration Number: NCT00099775

Locations: 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States

Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine

Phase 2

Completed

Conditions: Recurrent Thyroid Cancer
Stage IV Follicular Thyroid Cancer
Stage IV Papillary Thyroid Cancer

Interventions: Drug: romidepsin
Other: laboratory biomarker analysis
Procedure: positron emission tomography

First Posted Date: 2004-12-09

Last Posted Date: 2014-05-28

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 20

Registration Number: NCT00098813

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center at Suffolk, Commack, New York, United States

Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II

Completed

Conditions: Non-melanomatous Skin Cancer
Precancerous Condition

First Posted Date: 2004-12-09

Last Posted Date: 2015-04-30

Lead Sponsor: National Cancer Institute (NCI)

Registration Number: NCT00099112

Locations: 🇺🇸
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States

Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Phase 2

Completed

Conditions: Oral Leukoplakia
Head and Neck Cancer

Interventions: Drug: pioglitazone hydrochloride

First Posted Date: 2004-12-09

Last Posted Date: 2022-02-11

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 21

Registration Number: NCT00099021

Locations: 🇺🇸
University of Minnesota Medical Center-Fairview, Minneapolis, Minnesota, United States

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2004-12-09

Last Posted Date: 2014-01-27

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 24

Registration Number: NCT00099060

Locations: 🇨🇦
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
Tom Baker Cancer Centre - Calgary, Calgary, Alberta, Canada

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy